肝硬化患者的抗凝治疗：是并发症还是治疗契机？ - Suppr

Suppr

超能文献

Anticoagulation in patients with liver cirrhosis: complication or therapeutic opportunity?

作者信息

Jairath Vipul, Burroughs Andrew K

机构信息

Translational Gastroenterology Unit and NHS Blood andTransplant, Oxford University Hospitals, Oxford, UK.

出版信息

Gut. 2013 Apr;62(4):479-82. doi: 10.1136/gutjnl-2012-303088. Epub 2013 Jan 7.

DOI:10.1136/gutjnl-2012-303088

PMID:23300140

Abstract

摘要

相似文献

Anticoagulation in patients with liver cirrhosis: complication or therapeutic opportunity?

Gut. 2013 Apr;62(4):479-82. doi: 10.1136/gutjnl-2012-303088. Epub 2013 Jan 7.

Risk stratification in the management of portal vein thrombosis in cirrhosis.

J Gastrointestin Liver Dis. 2016 Mar;25(1):119-20. doi: 10.15403/jgld.2014.1121.251.qix.

The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? No.

Eur J Intern Med. 2010 Apr;21(2):65-9. doi: 10.1016/j.ejim.2010.02.001. Epub 2010 Feb 18.

Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH.

J Thromb Haemost. 2024 Sep;22(9):2653-2669. doi: 10.1016/j.jtha.2024.05.023. Epub 2024 May 31.

AGA Technical Review on Coagulation in Cirrhosis.

Gastroenterology. 2021 Nov;161(5):1630-1656. doi: 10.1053/j.gastro.2021.09.004. Epub 2021 Sep 25.

AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.

Gastroenterology. 2021 Nov;161(5):1615-1627.e1. doi: 10.1053/j.gastro.2021.08.015. Epub 2021 Sep 25.

Anticoagulation in cirrhosis: a new paradigm?

Clin Mol Hepatol. 2017 Mar;23(1):13-21. doi: 10.3350/cmh.2016.0110. Epub 2017 Mar 14.

The coagulation system in patients with end-stage liver disease.

Liver Int. 2015 Jan;35 Suppl 1:139-44. doi: 10.1111/liv.12723.

[Hemostasis and blood coagulation revisited: mechanisms and therapeutic implications].

J Pharm Belg. 2004;59(1):15-26.

[Cirrhosis and coagulation : implications for clinical practice].

Rev Med Suisse. 2021 Sep 8;17(749):1495-1498.

引用本文的文献

Relationship between coagulopathy score and survival in critically ill patients with liver cirrhosis and sepsis: a retrospective study.

BMC Infect Dis. 2025 Mar 26;25(1):418. doi: 10.1186/s12879-025-10848-z.

Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population-based cohort study.

Res Pract Thromb Haemost. 2022 Feb 24;6(2):e12668. doi: 10.1002/rth2.12668. eCollection 2022 Feb.

Advances in therapeutic options for portal hypertension.

Therap Adv Gastroenterol. 2018 Nov 25;11:1756284818811294. doi: 10.1177/1756284818811294. eCollection 2018.

Novel treatment options for portal hypertension.

Gastroenterol Rep (Oxf). 2017 May;5(2):90-103. doi: 10.1093/gastro/gox011. Epub 2017 Apr 18.

Von Willebrand factor deficiency reduces liver fibrosis in mice.

Toxicol Appl Pharmacol. 2017 Aug 1;328:54-59. doi: 10.1016/j.taap.2017.05.018. Epub 2017 May 17.

Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention.

Transplant Direct. 2016 Mar 1;2(4):e68. doi: 10.1097/TXD.0000000000000578. eCollection 2016 Apr.

Thrombin activation and liver inflammation in advanced hepatitis C virus infection.

World J Gastroenterol. 2016 May 14;22(18):4427-37. doi: 10.3748/wjg.v22.i18.4427.

Heparin Saline Versus Normal Saline for Flushing and Locking Peripheral Venous Catheters in Decompensated Liver Cirrhosis Patients: A Randomized Controlled Trial.

Medicine (Baltimore). 2015 Aug;94(31):e1292. doi: 10.1097/MD.0000000000001292.

Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review.

World J Gastroenterol. 2014 May 21;20(19):5737-45. doi: 10.3748/wjg.v20.i19.5737.

Clinical research priorities in adult congenital heart disease.

Int J Cardiol. 2014 Feb 15;171(3):351-60. doi: 10.1016/j.ijcard.2013.12.034. Epub 2013 Dec 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Anticoagulation in patients with liver cirrhosis: complication or therapeutic opportunity?

Gut. 2013 Apr;62(4):479-82. doi: 10.1136/gutjnl-2012-303088. Epub 2013 Jan 7.

Risk stratification in the management of portal vein thrombosis in cirrhosis.

J Gastrointestin Liver Dis. 2016 Mar;25(1):119-20. doi: 10.15403/jgld.2014.1121.251.qix.

The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? No.

Eur J Intern Med. 2010 Apr;21(2):65-9. doi: 10.1016/j.ejim.2010.02.001. Epub 2010 Feb 18.

Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH.

J Thromb Haemost. 2024 Sep;22(9):2653-2669. doi: 10.1016/j.jtha.2024.05.023. Epub 2024 May 31.

AGA Technical Review on Coagulation in Cirrhosis.

Gastroenterology. 2021 Nov;161(5):1630-1656. doi: 10.1053/j.gastro.2021.09.004. Epub 2021 Sep 25.

AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.

Gastroenterology. 2021 Nov;161(5):1615-1627.e1. doi: 10.1053/j.gastro.2021.08.015. Epub 2021 Sep 25.

Anticoagulation in cirrhosis: a new paradigm?

Clin Mol Hepatol. 2017 Mar;23(1):13-21. doi: 10.3350/cmh.2016.0110. Epub 2017 Mar 14.

The coagulation system in patients with end-stage liver disease.

Liver Int. 2015 Jan;35 Suppl 1:139-44. doi: 10.1111/liv.12723.

[Hemostasis and blood coagulation revisited: mechanisms and therapeutic implications].

J Pharm Belg. 2004;59(1):15-26.

[Cirrhosis and coagulation : implications for clinical practice].

Rev Med Suisse. 2021 Sep 8;17(749):1495-1498.

引用本文的文献

Relationship between coagulopathy score and survival in critically ill patients with liver cirrhosis and sepsis: a retrospective study.

BMC Infect Dis. 2025 Mar 26;25(1):418. doi: 10.1186/s12879-025-10848-z.

Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population-based cohort study.

Res Pract Thromb Haemost. 2022 Feb 24;6(2):e12668. doi: 10.1002/rth2.12668. eCollection 2022 Feb.

Advances in therapeutic options for portal hypertension.

Therap Adv Gastroenterol. 2018 Nov 25;11:1756284818811294. doi: 10.1177/1756284818811294. eCollection 2018.

Novel treatment options for portal hypertension.

Gastroenterol Rep (Oxf). 2017 May;5(2):90-103. doi: 10.1093/gastro/gox011. Epub 2017 Apr 18.

Von Willebrand factor deficiency reduces liver fibrosis in mice.

Toxicol Appl Pharmacol. 2017 Aug 1;328:54-59. doi: 10.1016/j.taap.2017.05.018. Epub 2017 May 17.

Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention.

Transplant Direct. 2016 Mar 1;2(4):e68. doi: 10.1097/TXD.0000000000000578. eCollection 2016 Apr.

Thrombin activation and liver inflammation in advanced hepatitis C virus infection.

World J Gastroenterol. 2016 May 14;22(18):4427-37. doi: 10.3748/wjg.v22.i18.4427.

Heparin Saline Versus Normal Saline for Flushing and Locking Peripheral Venous Catheters in Decompensated Liver Cirrhosis Patients: A Randomized Controlled Trial.

Medicine (Baltimore). 2015 Aug;94(31):e1292. doi: 10.1097/MD.0000000000001292.

Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review.

World J Gastroenterol. 2014 May 21;20(19):5737-45. doi: 10.3748/wjg.v20.i19.5737.

Clinical research priorities in adult congenital heart disease.

Int J Cardiol. 2014 Feb 15;171(3):351-60. doi: 10.1016/j.ijcard.2013.12.034. Epub 2013 Dec 24.